Does pharmaceutical advertising affect journal publication about dietary supplements?

BMC Complementary and Alternative Medicine

Volumn 8, Issue 1, 2008, Pages

  Kemper, Kathi J ^a   Hood, Kaylene L ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CALCIUM; CALCIUM CARBONATE; CENTRUM; FOLIC ACID; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; LAVENDER OIL; MINERAL; NON PRESCRIPTION DRUG; OMEGA 3 FATTY ACID; RETINOL; TEA TREE OIL; UNCLASSIFIED DRUG; VITAMIN; VITAMIN B GROUP; VITAMIN D; ZINC;

ALTERNATIVE MEDICINE; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG INFORMATION; DRUG MARKETING; DRUG RESEARCH; DRUG SAFETY; PUBLICATION; PUBLISHING; REVIEW; ADVERTIZING; ARTICLE; ATTITUDE TO HEALTH; CONFLICT OF INTEREST; DEMOGRAPHY; DRUG INDUSTRY; PILOT STUDY; STATISTICS; UTILIZATION REVIEW;

ADVERTISING AS TOPIC; CONFLICT OF INTEREST; DEMOGRAPHY; DIETARY SUPPLEMENTS; DRUG INDUSTRY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; JOURNALISM, MEDICAL; PILOT PROJECTS; PUBLISHING;

EID: 42449126152     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-8-11     Document Type: Review

References (42)

1. Eisenberg DM Kessler RC Foster C Norlock FE Calkins DR Delbanco TL Unconventional medicine in the United States. Prevalence, costs, and patterns of use N Engl J Med 1993, 328:246-252. 10.1056/ NEJM199301283280406 8418405
2. Eisenberg DM Davis RB Ettner SL Appel S Wilkey S Van Rompay M Kessler RC Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey JAMA 1998, 280:1569-1575. 10.1001/ jama.280.18.1569 9820257
3. Barnes PM Powell-Griner E McFann K Nahin RL Complementary and alternative medicine use among adults: United States, 2002 Adv Data 2004, 1-19. 15188733
4. Tindle HA Davis RB Phillips RS Eisenberg DM Trends in use of complementary and alternative medicine by US adults: 1997-2002 Altern Ther Health Med 2005, 11:42-49. 15712765
5. Bell RA Suerken CK Grzywacz JG Lang W Quandt SA Arcury TA Complementary and alternative medicine use among adults with diabetes in the United States Altern Ther Health Med 2006, 12:16-22. 17017751
6. Grzywacz JG Suerken CK Quandt SA Bell RA Lang W Arcury TA Older adults' use of complementary and alternative medicine for mental health: findings from the 2002 National Health Interview Survey J Altern Complement Med 2006, 12:467-473. 10.1089/acm.2006.12.467 16813511
7. Carlson MJ Krahn G Use of complementary and alternative medicine practitioners by people with physical disabilities: Estimates from a National US Survey Disabil Rehabil 2006, 28:505-513. 10.1080/ 09638280500212062 16513583
8. Saydah SH Eberhardt MS Use of complementary and alternative medicine among adults with chronic diseases: United States 2002 J Altern Complement Med 2006, 12:805-812. 10.1089/acm.2006.12.805 17034287
9. Pearson NJ Johnson LL Nahin RL Insomnia, trouble sleeping, and complementary and alternative medicine: Analysis of the 2002 national health interview survey data Arch Intern Med 2006, 166:1775-1782. 10.1001/archinte.166.16.1775 16983058
10. Kessler RC Soukup J Davis RB Foster DF Wilkey SA Van Rompay MM Eisenberg DM The use of complementary and alternative therapies to treat anxiety and depression in the United States Am J Psychiatry 2001, 158:289-294. 10.1176/appi.ajp.158.2.289 11156813
11. Kennedy J Herb and supplement use in the US adult population Clin Ther 2005, 27:1847-1858. 10.1016/j.clinthera.2005.11.004 16368456
12. Gardiner P Graham R Legedza AT Ahn AC Eisenberg DM Phillips RS Factors associated with herbal therapy use by adults in the United States Altern Ther Health Med 2007, 13:22-29. 17405675
13. Robbins JM Cleves MA Collins HB Andrews N Smith LN Hobbs CA Randomized trial of a physician-based intervention to increase the use of folic acid supplements among women Am J Obstet Gynecol 2005, 192:1126-1132. 10.1016/j.ajog.2004.10.620 15846191
14. Sibinga EM Ottolini MC Duggan AK Wilson MH Parent-pediatrician communication about complementary and alternative medicine use for children Clin Pediatr (Phila) 2004, 43:367-373. 15118780
15. Busse JW Heaton G Wu P Wilson KR Mills EJ Disclosure of natural product use to primary care physicians: A cross-sectional survey of naturopathic clinic attendees Mayo Clin Proc 2005, 80:616-623. 15887429
16. Bent S Ko R Commonly used herbal medicines in the United States: A review Am J Med 2004, 116:478-485. 10.1016/j.amjmed.2003.10.036 15047038
17. Beal T Kemper KJ Gardiner P Woods C Long-term impact of four different strategies for delivering an on-line curriculum about herbs and other dietary supplements BMC Med Educ 2006, 6:39. 1557850 16893458 10.1186/ 1472-6920-6-39
18. Cohen MH Hrbek A Davis RB Schachter SC Kemper KJ Boyer EW Eisenberg DM Emerging credentialing practices, malpractice liability policies, and guidelines governing complementary and alternative medical practices and dietary supplement recommendations: A descriptive study of 19 integrative health care centers in the United States Arch Intern Med 2005, 165:289-295. 10.1001/archinte.165.3.289 15710791
19. Eisenberg DM Advising patients who seek alternative medical therapies Ann Intern Med 1997, 127:61-69. 9214254
20. Gardiner P Graham RE Legedza AT Eisenberg DM Phillips RS Factors associated with dietary supplement use among prescription medication users Arch Intern Med 2006, 166:1968-1974. 10.1001/archinte.166.18.1968 17030829
21. Kemper KJ Gardiner P Gobble J Woods C Expertise about herbs and dietary supplements among diverse health professionals BMC Complement Altern Med 2006, 6:15. 1557537 16646964 10.1186/1472-6882-6-15
22. Manheimer E Berman B NCCAM support for the Cochrane Collaboration CAM Field Complement Ther Med 2003, 11:268-271. 10.1016/ S0965-2299(03)00128-6 15022665
23. Liu Y Doucette WR Farris KB Nayakankuppam D Drug information-seeking intention and behavior after exposure to direct-to-consumer advertisement of prescription drugs Res Social Adm Pharm 2005, 1:251-269. 17138477
24. Lyles A Direct marketing of pharmaceuticals to consumers Annu Rev Public Health 2002, 23:73-91. 10.1146/annurev.publhealth.23.100901.140537 11910055
25. Smith R Medical journals are an extension of the marketing arm of pharmaceutical companies PLoS Med 2005, 2:e138. 1140949 15916457 10.1371/ journal.pmed.0020138
26. Lexchin J Interactions between physicians and the pharmaceutical industry: What does the literature say? CMAJ 1993, 149:1401-1407. 1485922 8221424
27. Epstein RA Influence of pharmaceutical funding on the conclusions of meta-analyses Bmj 2007, 335:1167. 2128680 18024481 10.1136/ bmj.39381.655845.BE
28. Tsai AC Conflicts between commercial and scientific interests in pharmaceutical advertising for medical journals Int J Health Serv 2003, 33:751-768. 10.2190/K0JG-EXG1-FB12-0ANF 14758858
29. Brennan TA Rothman DJ Blank L Blumenthal D Chimonas SC Cohen JJ Goldman J Kassirer JP Kimball H Naughton J Smelser N Health industry practices that create conflicts of interest: A policy proposal for academic medical centers JAMA 2006, 295:429-433. 10.1001/jama.295.4.429 16434633
30. Coleman DL Kazdin AE Miller LA Morrow JS Udelsman R Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach Acad Med 2006, 81:154-160. 10.1097/ 00001888-200602000-00011 16436576
31. Lo B Wolf LE Berkeley A Conflict-of-interest policies for investigators in clinical trials N Engl J Med 2000, 343:1616-1620. 10.1056/ NEJM200011303432206 11096170
32. Kirch DG Conflict-of-interest management: Efforts and insights from the Association of American Medical Colleges Cleve Clin J Med 2007, 74(Suppl 2):S23-25. discussion S32-27. 17471619
33. Jacobson MF Sharpe VA Angell M Ashford NA Blum A Chary LK Cho M Coull BC Davis D Doolittle RF Editorial policies on financial disclosure Nat Neurosci 2003, 6:1001. 10.1038/nn1003-1001 14513030
34. Lexchin J Light DW Commercial influence and the content of medical journals BMJ 2006, 332:1444-1447. 1479665 16777891 10.1136/ bmj.332.7555.1444
35. McFadden DW Calvario E Graves C The devil is in the details: The pharmaceutical industry's use of gifts to physicians as marketing strategy J Surg Res 2007, 140:1-5. 10.1016/j.jss.2006.10.010 17481979
36. Wazana A Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA 2000 283 373 -380 10.1001/jama.283.3.373 10647801
37. Wilkes MS Kravitz RL Policies, practices, and attitudes of North American medical journal editors J Gen Intern Med 1995, 10:443-450. 10.1007/BF02599916 7472701
38. Friedman L Richter ED Conflicts of interest and scientific integrity Int J Occup Environ Health 2005, 11:205-206. 15875898
39. Buettner C Phillips RS Davis RB Gardiner P Mittleman MA Use of dietary supplements among United States adults with coronary artery disease and atherosclerotic risks Am J Cardiol 2007, 99:661-666. 10.1016/ j.amjcard.2006.09.116 17317368
40. NIH State-of-the-Science Conference Statement on Multivitamin/Mineral Supplements and Chronic Disease Prevention NIH Consens State Sci Statements 2006, 23:1-30.
41. North American Menopause Society The role of calcium in peri- and postmenopausal women 2006 position statement of the North American Menopause Society Menopause 2006, 13:862-877. quiz 878-880. 10.1097/ 01.gme.0000243566.25205.0b 17106282
42. Sood A Knudsen K Sood R Wahner-Roedler DL Barnes SA Bardia A Bauer BA Publication bias for CAM trials in the highest impact factor medicine journals is partly due to geographical bias J Clin Epidemiol 2007, 60:1123-1126. 10.1016/j.jclinepi.2007.01.009 17938053